The Siteman Cancer Center at Washington University is the recipient of two, multi-million dollar grants awarded by the National Cancer Institute. The grants total $26-million and will help establish the School of Medicine as a premier center for innovative leukemia research.
Doctors hope the research will lead to more personalized treatments for patients based on the unique makeup of their leukemia cells. They also hope to discover therapies that improve survival and reduce treatment-related side effects.
In addition, the grant funding will enable the Center to capitalize on research advances at the medical school in order to bring new investigational treatments into clinical trials.